Posts
Bethlehem, PA, USA, October 24, 2017- ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced that Emergent BioSolutions will equip their Baltimore, Maryland bulk manufacturing facility (Bayview), designated a Center for Innovation in Advanced Development and Manufacturing (CIADM), with an ABEC 4,000L CSR bioreactor. The system will be custom designed to Emergent’s process needs, operational requirements, and facility constraints, and will greatly expand cell culture capacity at the Bayview site.
Tools aid scale-up and comparison of single-use and stainless-steel bioreactors.
ISPE Biopharmaceutical ManufacturingEvents
December 4th – 6th, 2017
San Francisco, CA
ABEC increases the maximum capacity of its Custom Single Run (CSR®) Bioreactors to 4,000 liters, doubling the industry standard. Read more…
ABEC, Inc.
We provide engineered solutions and services for biotech manufacturing.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. For more information, review our Privacy Policy.